Medindia

X

Watson to Host Conference Call and Webcast to Discuss Second Quarter 2010 Earnings

Thursday, July 8, 2010 General News J E 4
Advertisement


MORRISTOWN, N.J., July 8 Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that the Company intends to release its second quarter 2010 financial results on Thursday, August 5, 2010 prior to the open of the U.S. financial markets. The Company will also host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on August 5, 2010 to discuss its financial results and provide an update on the Company's outlook for 2010. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Daylight Time on August 15, 2010. The replay may be accessed by dialing (800) 642-1687 and entering pass code 84949830. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code. To access the webcast, go to Watson's Investor Relations Web site at http://ir.watson.com. A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on urology and women's health. Watson has operations in many of the world's established and growing international markets.

For press releases and other company information, visit the Watson Web site at http://www.watson.com

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100121/LA41294LOGO )

SOURCE Watson Pharmaceuticals, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
US Patent Allowed for Spring Action That Separates...
S
Geisinger Implements MedEx System to Enhance Medic...